InvestorsHub Logo
icon url

Crow3

06/23/13 9:56 AM

#40481 RE: Crow3 #40480

Valimed made a fool out of BAXA, and the other distributers, as did all of the other so called products Make fools of all other distributers that tried.

Nearly all of the LOYAL shareholders have deserted cdex.

Not even the talented CAP'N can TIE A PRETTY RIBBON on such a sorry sow of a story.
icon url

capnmike

06/23/13 11:01 AM

#40483 RE: Crow3 #40480

JAMES G. STEVENSON, PHARM.D., FASHP, has been in constant touch on the phone and via e-mail with the senators and representatives from his state.

http://www.ashpintersections.org/2010/01/health-care-reform-and-the-health-system-pharmacist-a-primer/

He currently serves as Treasurer of the Hospital Pharmacy Section of the International Pharmaceutical Federation (FIP).

http://www.ashpfoundation.org/MainMenuCategories/CenterforPharmacyLeadership/PharmacyLeadershipAcademy/James-G-Stevenson.aspx

376 connections
http://www.linkedin.com/pub/james-stevenson/18/920/a03

Jim Stevenson - "I really believe having technology like this needs to be the standard around the country."

http://www.reuters.com/article/2008/01/07/idUS124032+07-Jan-2008+MW20080107

“I am pleased to join the Board of CDEX and look forward to working with my fellow directors to realize the full potential of CDEX’s life changing technologies. The company has developed valuable technology that could save thousands of lives every year through prevention of medication errors in the clinical environment. CDEX has a strong technology platform and vast market opportunity in healthcare and security both of which are key components for the future success of the Company. As a practicing pharmacist I recognize the prospects of the company and I will work to ensure that the best interests of shareholders, healthcare providers, and patients are represented on the board,” stated Dr. Stevenson.

http://cdex-inc.com/cdex-inc-appoints-dr-james-g-stevenson-to-the-cdex-board-of-directors/


5,200 doses of intravenous medications dispensed per day

Dr. James Stevenson was appointed by Governor Snyder to the Michigan Board of Pharmacy.

The Department of Pharmacy Services was honored with some significant national awards during this year

Peer-Reviewed Articles Published 2011-2012

Choe HM, Farris KB, Stevenson JG, Townsend K, Diez HL, Remington T, Rockafellow S, Shimp LA, Sy A, Wells T, Standiford CJ. Patient centered medical home: Developing, expanding and sustaining a role for pharmacists. Am J Health-Syst Pharm 2012;69 1063-1071

Hlubocky JM, Stuckey LJ, Schuman AD, Stevenson JG. Evaluation of a transplantation specialty pharmacy program. Am J Health Syst Pharm. 2012 Feb 15; 69(4):340-7. PMID 22302259

Tran M, Ciarkowski S, Wagner D, Stevenson JG. A case study on the safety impact of implementing smart patient-controlled analgesic pumps at a tertiary care academic medical center. Jt Comm J Qual Patient Saf. 2012 Mar;38(3):112-9. PMID 22435228

Kaakeh R, Sweet BV, Reilly C, Bush C, DeLoach S, Higgins B, Clark AM, Stevenson JG. Impact of drug shortages on US health systems. Am J Health-Syst Pharm 2011; 68:1811-1819

Stevenson, James
Leadership Lessons for Professional Success. Invited Commencement Speaker, Rush University Medical Center Pharmacy Residency Program, Chicago, IL, June 25, 2012.
Residency Training as a Core to the Future. Invited presentation at the Seventh Annual Michigan Society of Health-System Pharmacists Residency Conference, Lansing, MI, June 4, 2012.
Informal and Innovative Leadership. Invited Keynote Lecture, Initiation Ceremony of the Gamma Chi chapter of the Phi Lambda Sigma National Pharmacy Leadership Society, Wayne State University College of Pharmacy, Detroit, MI, April 6, 2012.
Academic Considerations with the Pharmacy Practice Model. Invited presentation at the Pharmacy Practice Model Initiative: Defining the Future of Pharmacy Practice, Cleveland Clinic, Cleveland, OH, July 22, 2011.

http://www.pharm.med.umich.edu/public/2012_annual_report/2012_Annual_Report.pdf

Enhanced photoemission spectroscopy for verification of high-risk i.v. medications

Yaman Kaakeh,
Hanna Phan,
Brian D. DeSmet,
Deborah A. Pasko,
Denise K. Glenn and
James G. Stevenson

Conclusion. A tabletop EPS device demonstrated acceptable sensitivity and specificity for validating the identity and concentrations of selected high-risk i.v. medications compounded for pediatric patients. The device may help prevent clinically important medication errors caused by inaccurate compounding.

http://www.ajhp.org/content/65/1/49

CDEX Ships ValiMed G4 Medication Validation System

Prominent Global Medical Technology Company to Use for Research and Development

http://finance.yahoo.com/news/CDEX-Ships-ValiMed-G4-iw-3043086989.html
icon url

pennstreet

06/26/13 10:43 AM

#40492 RE: Crow3 #40480

crow-----

Some should seriously take note that BOTH Dr.'s came to CDEX, A F T E R the departure of one Mp and Ts.

Hum, that horse and water thing just keeps making more and more sense, for some, lol.